This video is sponsored by the Duke Clinical Medical Series.
Topics include:
* 2005 Heart Failure Guideline
* Evidence-based drug selection
* Cardiac Resynchronization Treatment
* ICDs and Stage C Heart Failure
Dr. Joe Rogers has indicated that he is a member of the GlaxoSmithKline Speakers Bureau.
The guest faculty, William Abraham, MD, has indicated that he receives research/grant
support from Amgen, Biotronik, CHF Solutions, GlaxoSmithKline, The Heart Failure Society
of America, National Institues of Health, Medtronic Inc., Myogen Inc., Orqis Medical,
Otsuka Maryland Research Institute, Paracor In., and Scios Inc. He acts as a
consultant/speakers bureau member for Amgen, Astra Zeneca, Boehringer Ingelheim, CHF
Solutions, GlaxoSmithKline, Guidant Corp., Medtronic Inc., Merck & Co. Inc., Pfizer,
ResMed, Respironics, Scios Inc., and St. Jude Medical. He is a member of the advisory
boards for CardioKine, Cardiokinetix Inc., CHF Solutions, The Department of Veterans
Affairs Cooperative Studies Program, National Institutes of Health, and Savacor Inc. He
receives/has received honoraria from Astra Zeneca, Boehringer Ingelheim, GlaxoSmithKline,
Guidant Corp., Medtronic Inc., Merck & Co. Inc., Pfizer, ResMed, Repsironics, Scios
Inc., and St. Jude Medical.
|
|